John Sharman - Feb 24, 2022 Form 4 Insider Report for UNIVERSAL BIOSENSORS INC (UBI)

Role
Chief Executive Officer
Signature
/s/ John Sharman
Stock symbol
UBI
Transactions as of
Feb 24, 2022
Transactions value $
$0
Form type
4
Date filed
2/28/2022, 05:08 AM
Previous filing
Sep 14, 2021
Next filing
May 31, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UBI Common Stock Award $0 +30K $0.00 30K Feb 24, 2022 Direct
holding UBI Common Stock 276K Feb 24, 2022 By wife F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding UBI Stock Option (Right to Buy) 1.36M Feb 24, 2022 Common Stock 1.36M $0.20 Direct F2, F3
holding UBI Stock Options (Right to Buy) 1M Feb 24, 2022 Common Stock 1M $0.20 By wife F1, F2, F3
holding UBI Performance Rights 2.5M Feb 24, 2022 Common Stock 2.5M Direct F4
holding UBI Performance Rights 1.25M Feb 24, 2022 Common Stock 1.25M Direct F5
holding UBI Stock Options (Right to Buy) 2.36M Feb 24, 2022 Common Stock 2.36M $0.25 Direct F2, F3
holding UBI Stock Options (Right to Buy) 1.36M Feb 24, 2022 Common Stock 1.36M $0.30 Direct F2, F3
holding UBI Stock Options (Right to Buy) 1M Feb 24, 2022 Common Stock 1M $0.30 By superannuation fund F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of the shares held by his wife, and this report should not be deemed an admission that the reporting person is the beneficial owner of his wife's shares for purposes of Section 16 or for any other purpose.
F2 The price reported is stated in Australian dollars.
F3 The options are fully vested and became exercisable after September 24, 2020.
F4 Each performance right represents a contingent right to receive one share of common stock of Universal Biosensors, Inc. ("UBI"). The performance rights vest upon, among other triggers, UBI's market capitalization having achieved a specified threshold.
F5 Each performance right represents a contingent right to receive one share of common stock of UBI. The performance rights vest upon a change of control transaction with a value greater a specified threshold.